Moirae Generics Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 16-11-2024
- Paid Up Capital ₹ 1.93 M
as on 16-11-2024
- Company Age 14 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 56.24%
(FY 2023)
- Profit 29.07%
(FY 2023)
- Ebitda 39.52%
(FY 2023)
- Net Worth -89.79%
(FY 2023)
- Total Assets -3.54%
(FY 2023)
About Moirae Generics
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 1.93 M, as per Ministry of Corporate Affairs (MCA) records.
Nutan Vibhute and Pandurang Manapkar serve as directors at the Company.
- CIN/LLPIN
U51909DL2010FTC198694
- Company No.
198694
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
04 Feb 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Moirae Generics?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nutan Vibhute  | Director | 12-Oct-2013 | Current |
| Pandurang Manapkar | Director | 30-Aug-2019 | Current |
Financial Performance of Moirae Generics.
Moirae Generics Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 56.24% increase. The company also saw a substantial improvement in profitability, with a 29.07% increase in profit. The company's net worth observed a substantial decline by a decrease of 89.79%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Moirae Generics?
In 2023, Moirae Generics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Moirae Generics?
Unlock and access historical data on people associated with Moirae Generics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Moirae Generics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Moirae Generics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
